Karyopharm Therapeutics
Zachary Babbe is an accomplished marketing professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as the Director of HCP Marketing at Karyopharm Therapeutics Inc., Zachary leads strategic brand development for a commercial-stage oncology product, focusing on enhancing healthcare professional perceptions through innovative campaign optimization. Previously, Zachary held various marketing roles at AbbVie, including Consumer Marketing Manager II, where direct-to-consumer campaigns for leading immunology brands were developed. Zachary's earlier positions include account leadership roles at Intouch Solutions and AbelsonTaylor, where comprehensive marketing strategies and integrated campaigns were executed for prominent pharmaceutical clients. Zachary holds a Bachelor of Science in Business Administration with a focus on Marketing from the University of Dayton and completed an executive education program at Kellogg focused on brand strategies.
This person is not in any teams
This person is not in any offices
Karyopharm Therapeutics
13 followers
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).